Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Intellia Therapeutics (NTLA) Revenue: 2015-2024

Historic Revenue for Intellia Therapeutics (NTLA) over the last 10 years, with Dec 2024 value amounting to $57.9 million.

  • Intellia Therapeutics' Revenue rose 51.27% to $13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.5 million, marking a year-over-year increase of 33.52%. This contributed to the annual value of $57.9 million for FY2024, which is 59.55% up from last year.
  • According to the latest figures from FY2024, Intellia Therapeutics' Revenue is $57.9 million, which was up 59.55% from $36.3 million recorded in FY2023.
  • Over the past 5 years, Intellia Therapeutics' Revenue peaked at $58.0 million during FY2020, and registered a low of $33.1 million during FY2021.
  • For the 3-year period, Intellia Therapeutics' Revenue averaged around $48.8 million, with its median value being $52.1 million (2022).
  • Per our database at Business Quant, Intellia Therapeutics' Revenue tumbled by 43.01% in 2021 and then soared by 59.55% in 2024.
  • Yearly analysis of 5 years shows Intellia Therapeutics' Revenue stood at $58.0 million in 2020, then slumped by 43.01% to $33.1 million in 2021, then surged by 57.69% to $52.1 million in 2022, then tumbled by 30.40% to $36.3 million in 2023, then soared by 59.55% to $57.9 million in 2024.